ASND

NASDAQStock

Ascendis Pharma A/S

$225.13-3.88 (-1.70%)

52-Week Range

$137.41

$242.09

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.48

Volume

479.7K

Avg Volume

806.3K

Performance

+5.00%

+7.40%

+17.67%

YTD

+7.37%

+49.70%

+111.03%

+55.79%

Price Chart

ETF Exposure

ASND is held by 35 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
XBAK.DE	Xtrackers MSCI Pakistan Swap UCITS ETF 1C	3.11%	2,703	$538K	$17.6M	0.85%
FDG	American Century Focused Dynamic Growth ETF	2.87%	49,388	$10.5M	$337.7M	0.45%
AADR	DORSEY WRIGHT ADR ETF	2.47%	5,966	$1.4M	$55.5M	1.17%
AIIQ	AI Powered International Equity ETF	1.77%	350	$37K	$4.9M	0.79%
BBP	Virtus Biotech ETF	1.66%	3,534	$809K	$50.5M	0.34%
ILDR	First Trust Innovation Leaders ETF	1.43%	13,998	$3.2M	$218.1M	0.75%
FMED	FIDELITY DISRUPTIVE MEDICINE ETF	1.34%	3,865	$930K	$60.9M	0.50%
PFUT	Putnam Sustainable Future ETF	1.11%	19,070	$4.4M	$4.8M	0.65%
TCAF	T. Rowe Price Capital Appreciation Equity ETF	1.10%	300,208	$68.8M	$6.37B	0.31%
SBIO.L	Invesco NASDAQ Biotech UCITS ETF	1.07%	0	$0	$416.2M	0.40%
IBBQ	Invesco Nasdaq Biotechnology ETF	1.07%	3,474	$790K	$72.1M	0.19%
FFOG	Franklin Focused Growth ETF	0.93%	9,476	$2.2M	$230.7M	0.55%
IBB	iShares Biotechnology ETF	0.93%	340,531	$77.5M	$8.50B	0.44%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.78%	2,757	$631K	$86.8M	1.19%
HRTS	Tema Cardiovascular and Metabolic ETF	0.77%	1,777	$404K	$56.6M	0.99%
QQQJ	Invesco NASDAQ Next Gen 100 ETF	0.71%	27,378	$6.2M	$857.2M	0.15%
EQJS.L	Invesco NASDAQ Next Generation 100 UCITS ETF	0.71%	0	$0	$29.2M	0.25%
TNXT	T. Rowe Price Innovation Leaders ETF	0.66%	447	$102K	$15.8M	0.49%
QQJG	Invesco ESG NASDAQ Next Gen 100 ETF	0.55%	167	$38K	$6.7M	0.20%
FFTY	Innovator IBD 50 ETF	0.50%	1,943	$445K	$89.2M	0.70%
TMSL	T. Rowe Price Small-Mid Cap ETF	0.17%	11,501	$2.6M	$1.57B	0.55%
XUEK.L	Xtrackers S&P Europe ex UK UCITS ETF 1D	0.11%	1,507	$25.9M	$229.1M	0.09%
XUEK.SG	Xtrackers S&P Europe ex UK UCITS ETF	0.11%	1,507	$300K	$284.4M	0.00%
XS5E.SG	Xtrackers S&P 500 Swap UCITS ETF	0.10%	42,185	$8.4M	$9.17B	0.00%
XSXD.SG	Xtrackers S&P 500 Swap UCITS ETF	0.10%	42,185	$8.4M	$9.17B	0.00%
XWD1.F	Xtrackers MSCI World Swap UCITS ETF	0.09%	44,628	$8.9M	$2.17B	0.19%
XWD1.SG	Xtrackers MSCI World Swap UCITS ETF	0.09%	44,628	$8.9M	$9.68B	0.00%
XWEH.DE	Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged	0.09%	44,628	$8.9M	$9.60B	0.39%
BDVL	iShares Disciplined Volatility Equity Active ETF	0.08%	7,720	$1.8M	$1.46B	0.41%
PDN	Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF	0.06%	1,033	$235K	$373.9M	0.47%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.04%	14,273	$3.4M	$9.01B	0.21%
MFDX	PIMCO RAFI Dynamic Multi-Factor International Equity ETF	0.03%	648	$147K	$455.2M	0.40%
SPDW	State Street SPDR Portfolio Developed World ex-US ETF	0.03%	40,727	$9.3M	$37.56B	0.03%
IALT	iShares Systematic Alternatives Active ETF	0.02%	365	$83K	$114.5M	0.99%
IGDA.L	Invesco Dow Jones Islamic Global Developed Markets UCITS ETF	0.02%	0	$0	$1.12B	0.40%

About ASND ETF Exposure

Ascendis Pharma A/S (ASND) is held by 35 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $225.13. Investors can gain exposure to ASND through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ASND, sorted by portfolio weight.